Latest filing published 21 Jul 2026 for ProQR Therapeutics N.V., €225k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Bart Filius: trading record in brief
This profile gathers the share dealings of Bart Filius in ProQR Therapeutics N.V. In total, 2 filings cover trades dated from 26 June 2026 to 17 July 2026.
On the market, this insider has only ever bought: 2 purchases, €429k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The newest entry dates from 21 July 2026: an open-market purchase of €225k, in ProQR Therapeutics N.V. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Bart Filius
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 150,000 shares@ US$1.7195Ordinary SharesSEC:0001104659-26-085234:0Canonical exit: 15 Oct 2026 (T+90)
- 150,000 sharesOrdinary SharesSEC:0001104659-26-079316:0Canonical exit: 24 Sept 2026 (T+90)
2 of 2 declarations